Diabetes is an epidemic. There are 44 million (12.9%) people living with diabetes in North America today, and by 2040 there will be 60 million (14.7%).¹ Diabetic retinopathy is the leading cause of blindness in working-age adults. A paradigm shift is necessary to realize a significant decrease in the number of people suffering from severe vision loss and blindness because of undiagnosed diabetic retinopathy.

Welch Allyn is leading the way with a simple and affordable turnkey solution enabling diabetic retinal exams in primary care settings. Making diabetic retinal exams more accessible means more patients who are not receiving annual exams can be conveniently examined for diabetic retinopathy.

Download the whitepaper for more information on:

• A new, patient-centered approach to diabetic retinal exams.
• The benefits of teleretinal exams in primary care settings.
• Turnkey programs with hardware, software and diagnostic services.

¹IDF Diabetes Atlas, Seventh Edition 2015, page 82. www.idf.org.